Cocoa flavanol health claim becomes EU law

Barry Callebaut wins blood flow health claim for high-flavanol dark chocolate and cocoa-based beverages
Barry Callebaut wins blood flow health claim for high-flavanol dark chocolate and cocoa-based beverages

Related tags Cocoa flavanols Health claim European union Chocolate European commission Barry callebaut

Barry Callebaut’s cocoa flavanol health claim has been approved by EU Commission.

The claim​ says that 200 mg of cocoa flavanols either from cocoa beverages or dark chocolate contribute to normal blood flow.

200mg of cocoa flavanols daily, is equivalent to 2.5 high flavanol cocoa powder or 10g of high flavanol dark chocolate, about one fifth of a regular sized chocolate bar.

Barry Callebaut has propriety rights to the health claim for five years and will use it for cocoa powder and chocolate produced through its flavanol-preserving ACTICOA method.

Peter Boone, Chief Innovation Officer at Barry Callebaut, said: "Receiving the right to use a health claim on cocoa flavanols by the EU Commission is most valuable for us as it is a great reward for long years of extensive research. The health claim is opening up new market potential. Since we received the positive opinion from EFSA on our submitted health claim, we saw a lot of interest among our customers."

Barry Callebaut submitted the health claim in early 2012 and received a positive opinion from the European Food Safety Authority (EFSA) in July 2012. In January this year, the claim was reworded in a draft decision​ by the Commission.

The original wording read: "Cocoa flavanols help maintain endothelium-dependent vasodilation which contributes to normal blood flow." ​The claim now reads:"Cocoa flavanols help maintain the elasticity of blood vessels, which contributes to normal blood flow"

Related news

Show more

Related products

show more

MenaQ7® Matrix Enables Next-Level Formulations

MenaQ7® Matrix Enables Next-Level Formulations

Gnosis by Lesaffre | 01-Feb-2023 | Technical / White Paper

Enhancing the protection of the MK-7 molecule is crucial for creating complex formulations that will truly impact health. MenaQ7® Matrix offers the first...

Elasderma: Patented advance in molecule technology

Elasderma: Patented advance in molecule technology

Nutraceuticals Group | 05-Jan-2023 | Technical / White Paper

From Atlantic Cod, Elasderma is fully water soluble, additive free and a hydrolyzed form of Elastin that contains verifiable and quantitative levels of...

Related suppliers

Follow us

Products

View more

Webinars